307 related articles for article (PubMed ID: 9286219)
1. Colonic sulfide in pathogenesis and treatment of ulcerative colitis.
Roediger WE; Moore J; Babidge W
Dig Dis Sci; 1997 Aug; 42(8):1571-9. PubMed ID: 9286219
[TBL] [Abstract][Full Text] [Related]
2. Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.
De Preter V; Arijs I; Windey K; Vanhove W; Vermeire S; Schuit F; Rutgeerts P; Verbeke K
Inflamm Bowel Dis; 2012 Dec; 18(12):2371-80. PubMed ID: 22434643
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis.
Christl SU; Eisner HD; Dusel G; Kasper H; Scheppach W
Dig Dis Sci; 1996 Dec; 41(12):2477-81. PubMed ID: 9011461
[TBL] [Abstract][Full Text] [Related]
4. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis.
Moore J; Babidge W; Millard S; Roediger W
Dig Dis Sci; 1998 Jan; 43(1):162-5. PubMed ID: 9508519
[TBL] [Abstract][Full Text] [Related]
5. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis.
Babidge W; Millard S; Roediger W
Mol Cell Biochem; 1998 Apr; 181(1-2):117-24. PubMed ID: 9562248
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis.
Jørgensen J; Mortensen PB
Dig Dis Sci; 2001 Aug; 46(8):1722-32. PubMed ID: 11508674
[TBL] [Abstract][Full Text] [Related]
7. Luminal sulfide and large intestine mucosa: friend or foe?
Blachier F; Davila AM; Mimoun S; Benetti PH; Atanasiu C; Andriamihaja M; Benamouzig R; Bouillaud F; Tomé D
Amino Acids; 2010 Jul; 39(2):335-47. PubMed ID: 20020161
[TBL] [Abstract][Full Text] [Related]
8. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis.
Roediger WE; Duncan A; Kapaniris O; Millard S
Gastroenterology; 1993 Mar; 104(3):802-9. PubMed ID: 8440437
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of sulfate-reducing bacteria for ulcerative colitis].
Watanabe K; Mikamo H; Tanaka K
Nihon Rinsho; 2007 Jul; 65(7):1337-46. PubMed ID: 17642254
[TBL] [Abstract][Full Text] [Related]
10. In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet.
Khalil NA; Walton GE; Gibson GR; Tuohy KM; Andrews SC
Int J Food Sci Nutr; 2014 Feb; 65(1):79-88. PubMed ID: 23941288
[TBL] [Abstract][Full Text] [Related]
11. Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative Colitis.
Teigen LM; Geng Z; Sadowsky MJ; Vaughn BP; Hamilton MJ; Khoruts A
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31027194
[TBL] [Abstract][Full Text] [Related]
12. The colonic epithelium in ulcerative colitis: an energy-deficiency disease?
Roediger WE
Lancet; 1980 Oct; 2(8197):712-5. PubMed ID: 6106826
[TBL] [Abstract][Full Text] [Related]
13. Impaired detoxication of hydrogen sulfide in ulcerative colitis?
Picton R; Eggo MC; Langman MJ; Singh S
Dig Dis Sci; 2007 Feb; 52(2):373-8. PubMed ID: 17216575
[TBL] [Abstract][Full Text] [Related]
14. Thiolmethyltransferase activity in the human colonic mucosa: implications for ulcerative colitis.
Moore JW; Babidge WJ; Millard SH; Roediger WE
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):678-84. PubMed ID: 9407333
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway.
De Preter V; Geboes KP; Bulteel V; Vandermeulen G; Suenaert P; Rutgeerts P; Verbeke K
Aliment Pharmacol Ther; 2011 Sep; 34(5):526-32. PubMed ID: 21707682
[TBL] [Abstract][Full Text] [Related]
16. Detectable colonic nitrite levels in inflammatory bowel disease--mucosal or bacterial malfunction?
Roediger WE; Lawson MJ; Nance SH; Radcliffe BC
Digestion; 1986; 35(4):199-204. PubMed ID: 3817329
[TBL] [Abstract][Full Text] [Related]
17. Rhodanese, but not cystathionine-gamma-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: a sign of impaired colonic sulfide detoxification?
Taniguchi E; Matsunami M; Kimura T; Yonezawa D; Ishiki T; Sekiguchi F; Nishikawa H; Maeda Y; Ishikura H; Kawabata A
Toxicology; 2009 Oct; 264(1-2):96-103. PubMed ID: 19647029
[TBL] [Abstract][Full Text] [Related]
18. Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects.
Mills DJ; Tuohy KM; Booth J; Buck M; Crabbe MJ; Gibson GR; Ames JM
J Appl Microbiol; 2008 Sep; 105(3):706-14. PubMed ID: 18399977
[TBL] [Abstract][Full Text] [Related]
19. Ashkenazi Jews, sulfur gases, and ulcerative colitis.
Levine J; Furne JK; Levitt MD
J Clin Gastroenterol; 1996 Jun; 22(4):288-91. PubMed ID: 8771424
[TBL] [Abstract][Full Text] [Related]
20. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
